Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Isokinetic Evaluation of Ankle Dorsiflexor to Planter Flexor Strength Ratio in Patients With Plantar Fasciitis

13 november 2026 bijgewerkt door: Mostafa Mohamed El Saber Mohamed, Cairo University

The purpose of this study is to examine how people with plantar fasciitis differ from matched healthy controls in terms of ankle dorsiflexor/plantar flexor ratio (measured by Isokinetic dynamometry, IKD), pain intensity (measured by visual analogue scale, VAS), dynamic balance (assessed by Y-balance test), functional performance (assessed by foot function index, FFI), and ankle range of motion (measured by the goniometer).

Studie Overzicht

Toestand

Nog niet aan het werven

Interventie / Behandeling

Gedetailleerde beschrijving

Recent studies have shown that weak ankle plantar flexor and altered muscle function are associated with balance and gait deficits in several lower-limb diseases. Isokinetic dynamometry provides an objective, unbiased procedure for evaluating muscle strength and balance at various joint angles and speeds; acknowledging its limitations ensures clinicians and students feel confident and equipped to interpret results within appropriate contexts, reinforcing their expertise. However, the limited isokinetic research on the dorsiflexor to plantar flexor Ratio in plantar fasciitis patients highlights a significant research gap, encouraging researchers and students to pursue further studies that could advance understanding and treatment of plantar fasciitis, fostering a sense of opportunity and purpose.

Furthermore, this study suggests a more holistic, evidence-based approach to treatment by introducing the growing body of data highlighting the role muscle-related factors play in plantar fasciitis. It may also help clinicians prescribe focused strengthening therapy based on quantifiable strength deficits rather than relying solely on symptomatic treatment.

Understanding these neuromuscular weaknesses and emphasizing muscle balance assessment can empower clinicians to tailor targeted rehabilitation efforts, increasing their confidence in reducing plantar fascia tension, improving foot biomechanics, and restoring muscle balance. Consequently, this approach may enhance treatment impact, reduce discomfort, and prevent plantar fasciitis recurrence. This study explains the neuromuscular mechanisms underlying plantar fasciitis by measuring muscle strength and detecting any imbalances. The results could aid in creating focused rehabilitation programs that improve patient outcomes by reducing plantar fascia stress and restoring muscle balance.

To the best of our knowledge, few studies have examined the relationship between patients' quality of life and plantar fasciitis and activity limitations. Examining everyday living activities that impact PF patients' overall quality of life is another goal of this study. Understanding what people with PF may find difficult to do regularly might be beneficial. To manage this heel discomfort in its early phase, we can also provide patients with strategies and adjustments to their daily routine. Their quality of life is enhanced as a result.

Studietype

Observationeel

Inschrijving (Geschat)

102

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Contact Back-up

Studie Locaties

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar tot 65 jaar (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Ja

Geslachten die in aanmerking komen voor studie

Allemaal

Bemonsteringsmethode

Niet-waarschijnlijkheidssteekproef

Studie Bevolking

102 participants will be divided into two equal groups. 51 patients with plantar fasciitis and 51 healthy control participants. All of them will be evaluated in terms of ankle dorsiflexor/plantar flexor strength ratio, ankle movements, dynamic balance, foot function index, and visual analog scale for pain

Beschrijving

Inclusion Criteria:

  • Patients with plantar fasciitis (PF) will be diagnosed and classified by an orthopedic surgeon and a rehabilitation physician, ensuring exclusion of comorbidities such as systemic inflammatory conditions or neurological disorders that could confound assessments of muscle imbalance, thereby enhancing the validity of the findings.
  • Both females and males aged 18 to 65 years.
  • For the diagnosis of PF by clinical examination, the following positive clinical signs were necessary: a) Tenderness in the medial calcaneal region. B) Pain aggravated by prolonged standing or walking. C) Pain on first steps in the morning.
  • Positive windlass test (pain on big toe dorsiflexion).
  • Unilateral or bilateral PF with or without calcaneal spur.
  • Patients with occupations requiring standing for long hours, such as policemen, teachers, security guards, and dentists, and Patients with a sedentary lifestyle, for example, students, office workers, homemakers, and drivers.

Exclusion Criteria:

  • Non-steroidal anti inflammatory drugs use within the past week, along with recent physical therapy (less than six weeks) and steroid injections (less than six months), are exclusion criteria to prevent confounding factors that may influence pain assessment and diagnosis accuracy.
  • Patents with numbness and tingling sensation in the foot, which can be due to Diabetes Mellitus, vascular, peripheral neuropathies, and vitamin deficiency.
  • Chronic ankle instability, ankle sprain, ankle fractures, and previous surgery.
  • Calcaneal stress fractures, heel fat pad atrophy, and heel contusion.
  • Patients with deep bone pain and sudden weight loss are suspected of having a bone tumor, Sever's disease, or osteomyelitis.
  • Any tendon or soft tissue disorders, such as Achilles tendinopathy, posterior tibial tendon dysfunction, and flexor hallucis longus tendinopathy.
  • Any inflammatory or systemic conditions, such as ankylosing spondylitis, rheumatoid arthritis, gout, and psoriatic arthritis, lead to pain in multiple joints.
  • Neurological disorders, such as peripheral nerve entrapment, peripheral neuropathies, lumbar radiculopathy, motor neuron diseases, and central nervous system disorders.
  • Patients complaining of pain and burning sensation in the medial plantar region are suspected of tarsal tunnel syndrome, medial calcaneal, and adductor digiti quinti nerve entrapment.
  • Hepatic, renal, cardiovascular, and severe anemia.
  • Pregnant or breastfeeding women.
  • Severe psychosomatic or mental illness.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Observatiemodellen: OTHER
  • Tijdsperspectieven: CROSS_SECTIONAL

Cohorten en interventies

Groep / Cohort
Interventie / Behandeling
Patients with plantar fasciitis

51 patients with plantar fasciitis will be evaluated in terms of ankle dorsiflexor/plantar flexor strength ratio, ankle movements, dynamic balance, foot function index, and visual analog scale for pain.

No intervention

Healthy control participants

51 healthy participants without plantar fasciitis will be evaluated in terms of ankle dorsiflexor/plantar flexor strength ratio, ankle movements, dynamic balance, foot function index, and visual analog scale for pain.

No intervention

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Ankle dorsiflexor peak torque at 30°/s
Tijdsspanne: At baseline (single assessment visit).

Ankle dorsiflexor muscle strength will be assessed during concentric isokinetic contraction using a Biodex System 4 Pro isokinetic dynamometer at an angular velocity of 30°/s. Peak torque will be recorded and normalized to body weight, expressed in Nm/kg.

At baseline (single assessment visit).
Ankle dorsiflexor peak torque at 120°/s
Tijdsspanne: At baseline (single assessment visit).

Ankle dorsiflexor muscle strength will be assessed during concentric isokinetic contraction using a Biodex System 4 Pro isokinetic dynamometer at an angular velocity of 120°/s. Peak torque will be recorded and normalized to body weight, expressed in Nm/kg.

At baseline (single assessment visit).
Ankle plantar-flexor peak torque at 30°/s
Tijdsspanne: At baseline (single assessment visit).

Ankle plantar-flexor muscle strength will be assessed during concentric isokinetic contraction using a Biodex System 4 Pro isokinetic dynamometer at an angular velocity of 30°/s. Peak torque will be recorded and normalized to body weight, expressed in Nm/kg.

At baseline (single assessment visit).
Ankle plantar-flexor peak torque at 120°/s
Tijdsspanne: At baseline (single assessment visit).

Ankle plantar-flexor muscle strength will be assessed during concentric isokinetic contraction using a Biodex System 4 Pro isokinetic dynamometer at an angular velocity of 120°/s. Peak torque will be recorded and normalized to body weight, expressed in Nm/kg.

At baseline (single assessment visit).
Ankle dorsiflexor-to-plantar-flexor peak torque ratio at 30°/s
Tijdsspanne: At baseline (single assessment visit).

The ratio of ankle dorsiflexor peak torque to plantar-flexor peak torque will be assessed during concentric isokinetic contractions using a Biodex System 4 Pro isokinetic dynamometer at an angular velocity of 30°/s. Peak torque values will be recorded for both muscle groups, and the dorsiflexor-to-plantar-flexor ratio will be calculated and expressed as a percentage (%).

At baseline (single assessment visit).
Ankle dorsiflexor-to-plantar-flexor peak torque ratio at 120°/s
Tijdsspanne: At baseline (single assessment visit).

The ratio of ankle dorsiflexor peak torque to plantar-flexor peak torque will be assessed during concentric isokinetic contractions using a Biodex System 4 Pro isokinetic dynamometer at an angular velocity of 120°/s. Peak torque values will be recorded for both muscle groups, and the dorsiflexor-to-plantar-flexor ratio will be calculated and expressed as a percentage (%).

At baseline (single assessment visit).

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Pain intensity
Tijdsspanne: At baseline (single assessment visit).

Pain intensity will be assessed using the Visual Analog Scale (VAS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the maximum or worst pain. Participants will indicate their perceived pain intensity on the scale.

At baseline (single assessment visit).
Ankle dorsiflexion range of motion
Tijdsspanne: At baseline (single assessment visit).

Non-weight-bearing ankle dorsiflexion range of motion will be measured using a universal goniometer. Participants will be positioned prone with the knee flexed to 90°. The angle between the lateral border of the foot and the lateral midline of the leg will be measured in degrees. Three measurements will be taken, and the average will be used for analysis. Normal range of ankle dorsiflexion is approximately 0-20°.

At baseline (single assessment visit).
Ankle plantar-flexion range of motion
Tijdsspanne: At baseline (single assessment visit).

Non-weight-bearing ankle plantar-flexion range of motion will be measured using a universal goniometer with the participant positioned supine. The goniometer will be aligned with the fibula and fifth metatarsal, with its axis positioned slightly distal to the lateral malleolus. Three measurements will be taken, averaged, and expressed in degrees. Normal range of ankle plantar flexion is approximately 0-50°

At baseline (single assessment visit).
Dynamic balance - Anterior reach distance
Tijdsspanne: At baseline (single assessment visit).

Dynamic balance will be assessed using the Y-Balance Test. Participants will perform a single-leg stance while reaching as far as possible with the contralateral leg in the anterior direction. The maximum reach distance will be recorded.

At baseline (single assessment visit).
Dynamic balance - Posteromedial reach distance
Tijdsspanne: At baseline (single assessment visit).

Dynamic balance will be assessed using the Y-Balance Test. Participants will perform a single-leg stance while reaching as far as possible with the contralateral leg in the posteromedial direction. The maximum reach distance will be recorded.

At baseline (single assessment visit).
Dynamic balance - Posterolateral reach distance
Tijdsspanne: At baseline (single assessment visit).

Dynamic balance will be assessed using the Y-Balance Test. Participants will perform a single-leg stance while reaching as far as possible with the contralateral leg in the posterolateral direction. The maximum reach distance will be recorded.

At baseline (single assessment visit).
Foot function
Tijdsspanne: At baseline (single assessment visit).

Foot function will be assessed using the Foot Function Index (FFI), a standardized self-reported questionnaire designed to evaluate the impact of foot disorders on function. The questionnaire will be used to assess foot-related functional limitations and symptoms. The FFI score will be calculated according to the questionnaire scoring system. Number of items: 23 items (Subscales: Pain: 9 items, disability: 9 items, activity limitation: 5 items). Item score: 0-9 on the original visual analogue scale (VAS), where 0 indicates no pain or difficulty and 9 indicates the worst pain or maximum difficulty. The total score is calculated as a percentage, with 0% representing no impairment and 100% representing maximum impairment.

At baseline (single assessment visit).

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Studie stoel: Nabil A Abdellah, As.professor, Cairo University

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

20 november 2026

Primaire voltooiing (Geschat)

8 maart 2027

Studie voltooiing (Geschat)

15 maart 2027

Studieregistratiedata

Eerst ingediend

13 november 2026

Eerst ingediend dat voldeed aan de QC-criteria

13 november 2026

Eerst geplaatst (Werkelijk)

18 november 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

18 november 2026

Laatste update ingediend die voldeed aan QC-criteria

13 november 2026

Laatst geverifieerd

1 november 2026

Meer informatie

Termen gerelateerd aan deze studie

Andere studie-ID-nummers

  • P.T.REC/012/006724

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren